Dihydromyricetin Acts as a Potential Redox Balance Mediator in Cancer Chemoprevention

Dihydromyricetin (DHM) is a flavonoid extracted from the leaves and stems of the edible plant Ampelopsis grossedentata that has been used for Chinese Traditional Medicine. It has attracted considerable attention from consumers due to its beneficial properties including anticancer, antioxidative, and...

Full description

Saved in:
Bibliographic Details
Main Authors: Liang Chen, Meng Shi, Chenghao Lv, Ying Song, Yuanjie Wu, Suifei Liu, Zhibing Zheng, Xiangyang Lu, Si Qin
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2021/6692579
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563219788464128
author Liang Chen
Meng Shi
Chenghao Lv
Ying Song
Yuanjie Wu
Suifei Liu
Zhibing Zheng
Xiangyang Lu
Si Qin
author_facet Liang Chen
Meng Shi
Chenghao Lv
Ying Song
Yuanjie Wu
Suifei Liu
Zhibing Zheng
Xiangyang Lu
Si Qin
author_sort Liang Chen
collection DOAJ
description Dihydromyricetin (DHM) is a flavonoid extracted from the leaves and stems of the edible plant Ampelopsis grossedentata that has been used for Chinese Traditional Medicine. It has attracted considerable attention from consumers due to its beneficial properties including anticancer, antioxidative, and anti-inflammatory activities. Continuous oxidative stress caused by intracellular redox imbalance can lead to chronic inflammation, which is intimately associated with the initiation, promotion, and progression of cancer. DHM is considered a potential redox regulator for chronic disease prevention, and its biological activities are abundantly evaluated by using diverse cell and animal models. However, clinical investigations are still scanty. This review summarizes the current potential chemopreventive effects of DHM, including its properties such as anticancer, antioxidative, and anti-inflammatory activities, and further discusses the underlying molecular mechanisms of DHM in cancer chemoprevention by targeting redox balance and influencing the gut microbiota.
format Article
id doaj-art-66d7bfd7719f4482b9551ad0fb45119c
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-66d7bfd7719f4482b9551ad0fb45119c2025-02-03T01:20:44ZengWileyMediators of Inflammation0962-93511466-18612021-01-01202110.1155/2021/66925796692579Dihydromyricetin Acts as a Potential Redox Balance Mediator in Cancer ChemopreventionLiang Chen0Meng Shi1Chenghao Lv2Ying Song3Yuanjie Wu4Suifei Liu5Zhibing Zheng6Xiangyang Lu7Si Qin8College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, ChinaCollege of Food Science and Technology, Hunan Agricultural University, Changsha 410128, ChinaCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, ChinaCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, ChinaHunan Tea Group Co., Ltd., Changsha 410128, ChinaJiangxi Agricultural Engineering College, Yichun 331200, ChinaCollege of Food Science and Technology, Hunan Agricultural University, Changsha 410128, ChinaCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, ChinaCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, ChinaDihydromyricetin (DHM) is a flavonoid extracted from the leaves and stems of the edible plant Ampelopsis grossedentata that has been used for Chinese Traditional Medicine. It has attracted considerable attention from consumers due to its beneficial properties including anticancer, antioxidative, and anti-inflammatory activities. Continuous oxidative stress caused by intracellular redox imbalance can lead to chronic inflammation, which is intimately associated with the initiation, promotion, and progression of cancer. DHM is considered a potential redox regulator for chronic disease prevention, and its biological activities are abundantly evaluated by using diverse cell and animal models. However, clinical investigations are still scanty. This review summarizes the current potential chemopreventive effects of DHM, including its properties such as anticancer, antioxidative, and anti-inflammatory activities, and further discusses the underlying molecular mechanisms of DHM in cancer chemoprevention by targeting redox balance and influencing the gut microbiota.http://dx.doi.org/10.1155/2021/6692579
spellingShingle Liang Chen
Meng Shi
Chenghao Lv
Ying Song
Yuanjie Wu
Suifei Liu
Zhibing Zheng
Xiangyang Lu
Si Qin
Dihydromyricetin Acts as a Potential Redox Balance Mediator in Cancer Chemoprevention
Mediators of Inflammation
title Dihydromyricetin Acts as a Potential Redox Balance Mediator in Cancer Chemoprevention
title_full Dihydromyricetin Acts as a Potential Redox Balance Mediator in Cancer Chemoprevention
title_fullStr Dihydromyricetin Acts as a Potential Redox Balance Mediator in Cancer Chemoprevention
title_full_unstemmed Dihydromyricetin Acts as a Potential Redox Balance Mediator in Cancer Chemoprevention
title_short Dihydromyricetin Acts as a Potential Redox Balance Mediator in Cancer Chemoprevention
title_sort dihydromyricetin acts as a potential redox balance mediator in cancer chemoprevention
url http://dx.doi.org/10.1155/2021/6692579
work_keys_str_mv AT liangchen dihydromyricetinactsasapotentialredoxbalancemediatorincancerchemoprevention
AT mengshi dihydromyricetinactsasapotentialredoxbalancemediatorincancerchemoprevention
AT chenghaolv dihydromyricetinactsasapotentialredoxbalancemediatorincancerchemoprevention
AT yingsong dihydromyricetinactsasapotentialredoxbalancemediatorincancerchemoprevention
AT yuanjiewu dihydromyricetinactsasapotentialredoxbalancemediatorincancerchemoprevention
AT suifeiliu dihydromyricetinactsasapotentialredoxbalancemediatorincancerchemoprevention
AT zhibingzheng dihydromyricetinactsasapotentialredoxbalancemediatorincancerchemoprevention
AT xiangyanglu dihydromyricetinactsasapotentialredoxbalancemediatorincancerchemoprevention
AT siqin dihydromyricetinactsasapotentialredoxbalancemediatorincancerchemoprevention